TICE BCG (Organon USA Inc.)
Welcome to the PulseAid listing for the TICE BCG drug offered from Organon USA Inc.. This Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],BCG Vaccine [Chemical/Ingredient],Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC],Increased Macrophage Proliferation [PE],Increased Immunologically Active Molecule Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Organon USA Inc. |
| NON-PROPRIETARY NAME: | BACILLUS CALMETTE-GUERIN |
| SUBSTANCE NAME: | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],BCG Vaccine [Chemical/Ingredient],Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC],Increased Macrophage Proliferation [PE],Increased Immunologically Active Molecule Activity [PE] |
| ROUTE: | INTRAVESICAL |
| DOSAGE FORM: | POWDER, FOR SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1990-08-24 |
| END MARKETING DATE: | 0000-00-00 |
TICE BCG HUMAN PRESCRIPTION DRUG Details:
| Item Description | TICE BCG from Organon USA Inc. |
| LABELER NAME: | Organon USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/50mL) |
| START MARKETING DATE: | 1990-08-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0052-0602_f85f1cae-2113-4e38-b972-f8a59e1bf2bd |
| PRODUCT NDC: | 0052-0602 |
| APPLICATION NUMBER: | BLA102821 |
Other BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN Pharmaceutical Manufacturers / Labelers:
